Michelle Chung

Michelle Chung is an experienced venture partner at Panacea Venture, specializing in commercial assessments of investment opportunities across various therapeutic areas, including CNS and oncology. Additionally, Michelle holds the position of commercial advisor at Concentric Analgesics, Inc. and manages consulting efforts at mPWR10 Partners, assisting pharmaceutical and biotech clients with product development and market strategies. Michelle has previously served as vice president of marketing at Braeburn, leading commercialization strategies for opioid addiction therapies, and as senior director of global marketing at Teva Pharmaceuticals for COPAXONE in multiple sclerosis. With roles in marketing leadership at Iroko Pharmaceuticals, Anesiva, Cephalon, and GlaxoSmithKline, Michelle has developed a robust background in product launches, marketing strategies, and brand development, underpinned by a BA in Communications from Villanova University.